Table I. Summary of patient samples.
Clinical data are provided where available. M, male; F, female, n/a, not applicable.
| Identifier | Diagnosis | Age of onset | Age of death | Post-mortem interval | Gender |
|---|---|---|---|---|---|
| years | years | h | |||
| HSB 120 | Adenoleukodystrophy | 56 | M | ||
| CABM-BR19 | Adult NCL | 20 | 33 | F | |
| CABM-BR8 | Adult NCL | Late 30s | 50s | M | |
| HSB 2356 | Adult NCL | 33 | 40 | 8 | M |
| HSB 4165 | Adult NCL | 29 | 53 | 6.5 | M |
| UMB 338 | Alexander disease | 6.2 | 12 | M | |
| UMB 613 | Alexander disease | 14 | 7 | M | |
| UMB 575 | Krabbe disease | 1.4 | 4 | M | |
| CABM-BR21 | Late infantile NCL (CLN2) | M | |||
| UMB 784 | Late infantile NCL (CLN2) | 5.3 | 4 | F | |
| UMB 563 | Mucopolysaccharidosis IIIA | 11.3 | 12 | F | |
| UMB 821 | Neuromuscular disorder, undiagnosed | 3.6 | 8 | F | |
| HSB 238 | Normal control | n/a | 43 | F | |
| HSB 298 | Normal control | n/a | 19 | M | |
| HSB 304 | Normal control | n/a | 22 | M | |
| HSB 331 | Normal control | n/a | 16 | M | |
| HSB 712 | Normal control | n/a | 16 | M | |
| HSB 863 | Normal control | n/a | 40 | M | |
| UMB 1270 | Seizure disorder | 22 | 22 | F | |
| UMB 506 | Sudanophilic leukodystrophy | 0.4 | 5 | F | |
| HSB 148 | Tay-Sachs disease | 0.6 | 1.9 | F | |
| HSB 1183 | Unknown epilepsy | 0.2 | 1 | F | |
| CABM-BR1 | Unknown NCL | M | |||
| CABM-BR11 | Unknown NCL | F | |||
| CABM-BR23 | Unknown NCL | ||||
| CABM-BR24 | Unknown NCL | 24 | 20.6 | F | |
| CABM-BR25 | Unknown NCL | 8 | 16.5 | F | |
| CABM-BR32 | Unknown NCL | F | |||
| CABM-BR33 | Unknown NCL | 12.4 | F | ||
| CABM-BR34 | Unknown NCL | 7.5 | M | ||
| CABM-BR36 | Unknown NCL | F | |||
| HSB 4391 | Unknown NCL | 12 | F | ||
| HSB 2548 | Variant late infantile NCL | 7 | 25 | F |